Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.

Abstract

For roughly 25 years, 125I and 103Pd sources have been used in the treatment of various malignant diseases such as prostate cancer. Various new sources have been marketed and produced to meet the demand for new sources to use in treatment. Recently, IsoAID LLC created the ADVANTAGE 103Pd source. Various dosimetric parameters must be determined to facilitate… (More)

Topics

Cite this paper

@article{Sowards2007MonteCD, title={Monte Carlo dosimetric characterization of the IsoAid ADVANTAGE 103Pd brachytherapy source.}, author={Keith T. Sowards}, journal={Journal of applied clinical medical physics}, year={2007}, volume={8 2}, pages={18-25} }